The NCCN Guidelines for Soft Tissue Sarcoma provide recommendations for the diagnosis, evaluation, treatment, and follow-up for patients with soft tissue sarcomas. These NCCN Guidelines Insights summarize the panel discussion behind recent important updates to the guidelines, including the development of a separate and distinct guideline for gastrointestinal stromal tumors (GISTs); reconception of the management of desmoid tumors; inclusion of further recommendations for the diagnosis and management of extremity/body wall, head/neck sarcomas, and retroperitoneal sarcomas; modification and addition of systemic therapy regimens for sarcoma subtypes; and revision of the principles of radiation therapy for soft tissue sarcomas.
CITATION STYLE
von Mehren, M., Kane, J. M., Bui, M. M., Choy, E., Connelly, M., Dry, S., … George, G. V. (2020, December 1). Soft Tissue Sarcoma, Version 1.2021: Featured updates to the NCCN guidelines. JNCCN Journal of the National Comprehensive Cancer Network. Harborside Press. https://doi.org/10.6004/JNCCN.2020.0058
Mendeley helps you to discover research relevant for your work.